cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Cabaletta Bio Inc
10 own
12 watching
Current Price
$11.81
$-0.38
(-3.12%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
780.55M
52-Week High
52-Week High
26.35000
52-Week Low
52-Week Low
9.02000
Average Volume
Average Volume
0.77M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization780.55M
icon52-Week High26.35000
icon52-Week Low9.02000
iconAverage Volume0.77M
iconDividend Yield--
iconP/E Ratio--
What does the Cabaletta Bio Inc do?
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce disease-causing autoantibodies or pathogenic B cells. The company s lead product candidate is DSG3-CAART, which is in Phase I clinical trial for the treatment of mucosal pemphigus vulgaris, an autoimmune blistering skin disease, and Hemophilia A with Factor VIII alloantibodies. Its product candidate pipeline also includes MuSK-CAART, a preclinical stage product to treat a subset of patients with myasthenia gravis; FVIII-CAART, a discovery stage product to treat a subset of patients with Hemophilia A; and DSG3/1-CAART, a discovery stage product for the treatment of mucocutaneous pemphigus vulgaris. It has a collaboration with the University of Pennsylvania; and research agreement with The Regents of the University of California. The company was formerly known as Tycho Therapeutics, Inc. and changed its name to Cabaletta Bio, Inc. in August 2018. Cabaletta Bio, Inc. was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania.
Read More
How much money does Cabaletta Bio Inc make?
News & Events about Cabaletta Bio Inc.
Tickeron - Stocks
10 months ago
This indicator may be signaling CABA's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...
Tickeron - Stocks
10 months ago
Over the last three days, A.I.dvisor has detected that CABA's AroonUp green line (see chart) is above 70, while the AroonDown red line is below 30. When the green line goes above 70 while the red...
Stock Options Channel
10 months ago
Investors considering a purchase of Cabaletta Bio Inc (CABA) stock, but cautious about paying the going market price of 12.74/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the February 2024 ...
Globe Newswire
1 year ago
IND application cleared within 6 months of in-licensing CABA-201 binder CABA-201 data package and experience from prior autoimmune cell therapy INDs informed Phase 1/2 clinical trial design, including the initial dose to be evaluated and the patient dosing intervals PHILADELPHIA, March 31, 2023 (...
Ticker Report
1 year ago
Cabaletta Bio (NASDAQ:CABA Get Rating)s stock had its buy rating restated by equities research analysts at Chardan Capital in a research note issued on Wednesday, Benzinga reports. They currently have a $12.00 price objective on the stock. Chardan Capitals target ...
Frequently Asked Questions
Frequently Asked Questions
What is Cabaletta Bio Inc share price today?
plus_minus_icon
Can Indians buy Cabaletta Bio Inc shares?
plus_minus_icon
How can I buy Cabaletta Bio Inc shares from India?
plus_minus_icon
Can Fractional shares of Cabaletta Bio Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Cabaletta Bio Inc stocks?
plus_minus_icon
What is today’s traded volume of Cabaletta Bio Inc?
plus_minus_icon
What is today’s market capitalisation of Cabaletta Bio Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Cabaletta Bio Inc?
plus_minus_icon
What percentage is Cabaletta Bio Inc down from its 52-Week High?
plus_minus_icon
What percentage is Cabaletta Bio Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$11.81
$-0.38
(-3.12%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00